1. Adams C, Bergman H, Irving C. Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev. 2013;11:CD003082.
2. Beresford R, Ward A. Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs. 1987;33(1):31–49.
3. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev. 2006;19:CD004362.
4. Essali A, Turkmani K, Aboudamaah S, AbouDamaah A, Diaa Aldeen MR, Marwa ME, AlMounayer N. Haloperidol discontinuation for people with schizophrenia. Cochrane Database Syst Rev. 2019;4:CD011408.
5. Grange B, Albu S. The haloperidol story. Ann Clin Psychiatry. 2005;17:137–40.